TSXV:CLAS.H - Post by User
Comment by
JMark80on Jun 03, 2020 6:41pm
215 Views
Post# 31109038
RE:RE:RE:Stock price
RE:RE:RE:Stock priceBoth NO, but different administrations for different purposes. SaNOtize is already in phase 2. R-107 is still pre-clinical after receiving BARDA contract for CILI in 2016. If Salzman had already completed a safety/pharmacokinetic trial, and submitted a phase 2 for COVID 2 months ago, I'd be optimistic. No point developing this unless BARDA pays for it, it won't be needed.